» Articles » PMID: 28904608

The Chemistry and Biology of Mycolactones

Overview
Specialty Chemistry
Date 2017 Sep 15
PMID 28904608
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Mycolactones are a group of macrolides excreted by the human pathogen , which exhibit cytotoxic, immunosuppressive and analgesic properties. As the virulence factor of , mycolactones are central to the pathogenesis of the neglected disease Buruli ulcer, a chronic and debilitating medical condition characterized by necrotic skin ulcers. Due to their complex structure and fascinating biology, mycolactones have inspired various total synthesis endeavors and structure-activity relationship studies. Although this review intends to cover all synthesis efforts in the field, special emphasis is given to the comparison of conceptually different approaches and to the discussion of more recent contributions. Furthermore, a detailed discussion of molecular targets and structure-activity relationships is provided.

Citing Articles

Genomic insights into the plasmidome of non-tuberculous mycobacteria.

Diricks M, Maurer F, Dreyer V, Barilar I, Utpatel C, Merker M Genome Med. 2025; 17(1):19.

PMID: 40038805 PMC: 11877719. DOI: 10.1186/s13073-025-01443-7.


Exploring Mycolactone-The Unique Causative Toxin of Buruli Ulcer: Biosynthetic, Synthetic Pathways, Biomarker for Diagnosis, and Therapeutic Potential.

Akolgo G, Asiedu K, Amewu R Toxins (Basel). 2024; 16(12.

PMID: 39728786 PMC: 11678992. DOI: 10.3390/toxins16120528.


Mycolactone A vs. B: Multiscale Simulations Reveal the Roles of Localization and Association in Isomer-Specific Toxicity.

Nguyen J, da Hora G, Swanson J Toxins (Basel). 2023; 15(8).

PMID: 37624243 PMC: 10467071. DOI: 10.3390/toxins15080486.


From Bacterial Toxin to Therapeutic Agent: The Unexpected Fate of Mycolactone.

Ricci D, Demangel C Toxins (Basel). 2023; 15(6).

PMID: 37368670 PMC: 10303314. DOI: 10.3390/toxins15060369.


Sec61 blockade therapy overrides resistance to proteasome inhibitors and immunomodulatory drugs in multiple myeloma.

Domenger A, Ricci D, Mayau V, Majlessi L, Marcireau C, Dadaglio G Front Oncol. 2023; 13:1110916.

PMID: 36776330 PMC: 9911829. DOI: 10.3389/fonc.2023.1110916.


References
1.
Guerinot A, Reymond S, Cossy J . Iron-catalyzed cross-coupling of alkyl halides with alkenyl grignard reagents. Angew Chem Int Ed Engl. 2007; 46(34):6521-4. DOI: 10.1002/anie.200702206. View

2.
Namba K, Cui S, Wang J, Kishi Y . A new method for translating the asymmetric Ni/Cr-mediated coupling reactions from stoichiometric to catalytic. Org Lett. 2005; 7(24):5417-9. DOI: 10.1021/ol052084s. View

3.
Tornoe C, Christensen C, Meldal M . Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(i)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. J Org Chem. 2002; 67(9):3057-64. DOI: 10.1021/jo011148j. View

4.
Cadapan L, Arslanian R, Carney J, Zavala S, Small P, Licari P . Suspension cultivation of Mycobacterium ulcerans for the production of mycolactones. FEMS Microbiol Lett. 2001; 205(2):385-9. DOI: 10.1111/j.1574-6968.2001.tb10977.x. View

5.
Willson S, Kaufman M, Merritt R, Williamson H, Malakauskas D, Benbow M . Fish and amphibians as potential reservoirs of Mycobacterium ulcerans, the causative agent of Buruli ulcer disease. Infect Ecol Epidemiol. 2013; 3. PMC: 3580280. DOI: 10.3402/iee.v3i0.19946. View